WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004095027) DIAGNOSTIC ASSAY FOR ANTI-VON WILLEBRAND FACTOR CLEAVING PROTEASE (ADAMTS13) ANTIBODIES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/095027    International Application No.:    PCT/EP2004/003483
Publication Date: 04.11.2004 International Filing Date: 01.04.2004
IPC:
C12Q 1/56 (2006.01), G01N 33/86 (2006.01)
Applicants: BAXTER INTERNATIONAL INC. [US/US]; One Baxter Parkway, Deerfield, IL 60015 (US) (For All Designated States Except US).
BAXTER HEALTHCARE S.A. [CH/CH]; Hertistrasse 2, CH-8304 Wallisellen (CH) (For All Designated States Except US).
SCHEIFLINGER, Friedrich [AT/AT]; (AT) (For US Only).
RIEGER, Manfred [AT/AT]; (AT) (For US Only).
PLAIMAUER, Barbara [AT/AT]; (AT) (For US Only)
Inventors: SCHEIFLINGER, Friedrich; (AT).
RIEGER, Manfred; (AT).
PLAIMAUER, Barbara; (AT)
Agent: PERREY, Ralf; Müller-Boré & Partner, Grafinger Strasse 2, 81671 München (DE)
Priority Data:
10/422,052 22.04.2003 US
Title (EN) DIAGNOSTIC ASSAY FOR ANTI-VON WILLEBRAND FACTOR CLEAVING PROTEASE (ADAMTS13) ANTIBODIES
(FR) ESSAI DIAGNOSTIQUE POUR ANTICORPS ANTI-PROTEASE DE CLIVAGE DE FACTEUR DE WILLEBRAND (ADAMTS13)
Abstract: front page image
(EN)This invention relates to a kit to be used in an assay system for determination of an anti-von Willebrand Factor-cleaving protease ('anti-­vWF-cp') antibody in a sample. The kit comprises vWF-cp and/or vWF-fragment(s) immobilized on a solid phase. The kit can be used in a method for determination of anti-vWF-cp antibodies from a patient, for the diagnosis of disorders associated with the occurrence of anti-­vWF-cp-antibodies, and the differentiation of various forms of thrombotic microangiopathy.
(FR)La présente invention concerne un kit à utiliser dans un système d'essai qui sert à déterminer la présence dans un échantillon d'un anticorps anti-protéase de clivage de facteur de Willebrand ('anti-vWF-cp'). Le kit comprend un ou plusieurs fragments de vWF-cp et/ou de vWF immobilisés sur une phase solide. Le kit peut être utilisé dans le cadre d'un procédé pour déterminer la présence d'anticorps anti-vWF-cp chez un patient, pour le diagnostic de troubles liés à la présence de ces anticorps, et la différenciation de différentes formes de microangiopathie thrombotique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)